Fresenius Extends $2B Merger Deadline After Shutdown
Germany's Fresenius Medical has extended the deadline for its $2 billion merger with Massachusetts-based medical technology company NxStage Medical until it is clear that the U.S. government is back on its...To view the full article, register now.
Already a subscriber? Click here to view full article